Evidence map›Paper›PMID 28327614›Full record

ArticleScientific reports2017

Partial Reprogramming of Pluripotent Stem Cell-Derived Cardiomyocytes into Neurons.

Wenpo Chuang, Arun Sharma, Praveen Shukla, Guang Li, Moritz Mall, Kuppusamy Rajarajan, Oscar J Abilez, Ryoko Hamaguchi, Joseph C Wu, Marius Wernig and 1 more

Abstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Extracellular matrix grafts: From preparation to application (Review).International journal of molecular medicine · 2021
    Review
  9. Review
  10. Review
  11. Direct cell-fate conversion of somatic cells: Toward regenerative medicine and industries.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2020
    Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Wenpo ChuangStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
Arun SharmaStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
Praveen ShuklaStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
Guang LiStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
Moritz MallInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Kuppusamy RajarajanStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
Oscar J AbilezStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
Ryoko HamaguchiStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
Joseph C WuStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
Marius WernigInstitute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Sean M WuStanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.

Funding

Induced pluripotent stem cells in the understanding and treatment of heart diseaseU01HL099776 · NHLBI · STANFORD UNIVERSITY · PI LONGAKER, MICHAEL T, WU, JOSEPH C. · 2009 to 2015
$8.2M
Human Induced Pluripotent Stem Cells for Cardiovascular Disease ModelingR01HL113006 · NHLBI · STANFORD UNIVERSITY · PI WU, JOSEPH C. · 2012 to 2025
$6.8M
Enabling Technologies for Human-Machine Hybrid TissuesDP1LM012179 · NLM · STANFORD UNIVERSITY · PI WU, SEAN M · 2014 to 2018
$3.8M
Generation of functional organs via developmental chimerismDP2OD004411 · OD · STANFORD UNIVERSITY · PI WU, SEAN M · 2008 to 2008
$2.5M
Optogenetic Engineered Heart Muscle for Disease ModelingK01HL130608 · NHLBI · STANFORD UNIVERSITY · PI ABILEZ, OSCAR JOHN · 2016 to 2020
$862k
NHLBI NIH HHS K01 HL130608NHLBI NIH HHS R01 HL113006NHLBI NIH HHS U01 HL099776NIH HHS DP2 OD004411NLM NIH HHS DP1 LM012179
6 · The paper itself

Abstract

Direct reprogramming of somatic cells has been demonstrated, however, it is unknown whether electrophysiologically-active somatic cells derived from separate germ layers can be interconverted. We demonstrate that partial direct reprogramming of mesoderm-derived cardiomyocytes into neurons is feasible, generating cells exhibiting structural and electrophysiological properties of both cardiomyocytes and neurons. Human and mouse pluripotent stem cell-derived CMs (PSC-CMs) were transduced with the neurogenic transcription factors Brn2, Ascl1, Myt1l and NeuroD. We found that CMs adopted neuronal morphologies as early as day 3 post-transduction while still retaining a CM gene expression profile. At week 1 post-transduction, we found that reprogrammed CMs expressed neuronal markers such as Tuj1, Map2, and NCAM. At week 3 post-transduction, mature neuronal markers such as vGlut and synapsin were observed. With single-cell qPCR, we temporally examined CM gene expression and observed increased expression of neuronal markers Dcx, Map2, and Tubb3. Patch-clamp analysis confirmed the neuron-like electrophysiological profile of reprogrammed CMs. This study demonstrates that PSC-CMs are amenable to partial neuronal conversion, yielding a population of cells exhibiting features of both neurons and CMs.

Indexed as

Cell DifferentiationCellular ReprogrammingAnimalsBiomarkersCell LineDoublecortin ProteinElectrophysiological PhenomenaEmbryonic Stem CellsFluorescent Antibody TechniqueGene ExpressionGenes, ReporterMiceMyocytes, CardiacNeuronsPhenotypePluripotent Stem CellsBiomarkersDcx protein, mouseDoublecortin Protein

Identifiers

PMID28327614
PMCPMC5361100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.